You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Levodopa

Showing 26 - 50 of 838
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anhedonia, Depression Trial in Atlanta (Carbidopa Levodopa, Placebo)

Not yet recruiting
  • Anhedonia
  • Depression
  • Carbidopa Levodopa
  • Placebo
  • Atlanta, Georgia
    Emory University Hospital
Oct 4, 2023

Diabetic Retinopathy Trial in Decatur (Sinemet CR, )

Enrolling by invitation
  • Diabetic Retinopathy
  • Sinemet CR
  • placebo
  • Decatur, Georgia
    Atlanta VA Medical and Rehab Center, Decatur, GA
Jul 14, 2022

Parkinson Disease Trial in France (PR Oxycodone, Levodopa, Oxycodone Placebo)

Completed
  • Parkinson Disease
  • PR Oxycodone
  • +3 more
  • Aix-en-Provence, France
  • +17 more
Feb 28, 2022

Parkinson Disease Trial in Shanghai (WD-1603 Carbidopa-Levodopa Extended-Release Tablets, Placebo)

Recruiting
  • Parkinson Disease
  • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
  • Placebo
  • Shanghai, Shanghai, China
    Shanghai Huashan Hospital
Oct 28, 2021

Parkinson's Disease Trial in Saint Louis (Levodopa)

Completed
  • Parkinson's Disease
  • Levodopa
  • Saint Louis, Missouri
    Washington University School of Medicine, Movement Disorders Cen
Oct 12, 2022

ABBV-951 Subcutaneous Infusion to Assess Change in Disease

Not yet recruiting
  • Parkinson's Disease (PD)
    • (no location specified)
    Oct 25, 2023

    Udall Project 2 Aim 2A&C

    Not yet recruiting
    • Parkinson Disease
    • observational-- no intervention
    • (no location specified)
    Dec 12, 2022

    Parkinson Disease Trial (Opicapone, L-DOPA/DDCI)

    Not yet recruiting
    • Parkinson Disease
    • (no location specified)
    Oct 13, 2021

    Spinal Cord Injuries, Drug Effect Trial in Lausanne (Buspirone, Levodopa-Carbidopa, Buspirone + Levodopa-Carbidopa)

    Enrolling by invitation
    • Spinal Cord Injuries
    • Drug Effect
    • Lausanne, Vaud, Switzerland
      CHUV
    May 25, 2022

    Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)

    Suspended
    • Depressive Disorder
    • New York, New York
      New York State Psychiatric Institute
    Jan 26, 2022

    Stroke Trial in Charlestown (Placebo, Levodopa / Carbidopa, Armeo)

    Withdrawn
    • Stroke
    • Placebo
    • +2 more
    • Charlestown, Massachusetts
      Spaulding Rehabilitation Hospital
    Dec 17, 2021

    Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)

    Recruiting
    • Late Life Depression
    • +4 more
    • Nashville, Tennessee
      Vanderbilt Psychiatric Hospital
    Feb 23, 2022

    Parkinson's Disease, Obstructive Sleep Apnea Trial in Montreal (Sinemet CR, Placebo oral capsule)

    Recruiting
    • Parkinson's Disease
    • Obstructive Sleep Apnea
    • Sinemet CR
    • Placebo oral capsule
    • Montreal, Quebec, Canada
      McGill University Health Centre
    Aug 28, 2021

    Gut Microbiome in Patients With Parkinson's Disease

    Completed
    • Parkinson Disease
    • Low dose levodopa
    • High dose levodopa
    • Chicago, Illinois
      Rush University Medical Center
    Jul 1, 2021

    Parkinson Disease, Dyskinesia, Medication-Induced Trial in Lublin, Warszawa, Oswiecim (CPL500036 - low dose, CPL500036 - high

    Recruiting
    • Parkinson Disease
    • Dyskinesia, Medication-Induced
    • CPL500036 - low dose
    • +2 more
    • Lublin, Lubelskie, Poland
    • +3 more
    May 9, 2022

    Vigor and the LDR in Parkinson Disease

    Recruiting
    • Parkinson Disease
    • carbidopa/levodopa, as prescribed by treating physician
    • Ann Arbor, Michigan
      University of Michigan
    Dec 1, 2022

    Small Intestine and Blood Fingerprint Study in Parkinson's

    Not yet recruiting
    • Parkinson Disease
    • Fluid biopsy capsule
    • Levodopa-Carbidopa Immediate Release
    • Calgary, Alberta, Canada
      University of Calgary
    Aug 15, 2023

    Parkinson Disease Trial in Mansoura (carbidopa-levodopa, Pentoxifylline 400 MG)

    Not yet recruiting
    • Parkinson Disease
    • Mansoura, Egypt
      Faculty of Medicine, Mansoura University
    Jul 25, 2023

    Parkinson Disease Trial in United States (NE3107, )

    Active, not recruiting
    • Parkinson Disease
    • Englewood, Colorado
    • +15 more
    Nov 2, 2022

    Parkinson's Disease Trial in Japan (TVP-1012 1mg)

    Completed
    Has Results
    • Parkinson's Disease
    • TVP-1012 1mg
    • Nagoya, Aichi, Japan
    • +23 more
    Feb 16, 2022

    Advanced Parkinson's Disease Trial (Levodopa-Carbidopa Intestinal Gel, Percutaneous Endoscopic Gastrostomy with Jejunal

    Completed
    Has Results
    • Advanced Parkinson's Disease
    • Levodopa-Carbidopa Intestinal Gel
    • +2 more
    • (no location specified)
    Jul 14, 2021

    Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias Trial in United States (Dipraglurant)

    Recruiting
    • Parkinson Disease
    • +2 more
    • Augusta, Georgia
    • +6 more
    Apr 18, 2022

    Dyskinesias, Movement Disorders, CNS Diseases Trial in United States (Ketamine, Midazolam)

    Active, not recruiting
    • Dyskinesias
    • +4 more
    • Tucson, Arizona
    • +6 more
    Feb 16, 2022

    Parkinson Disease Trial (Stalevo, Carbidopa and Levodopa Controlled Release Tablets)

    Not yet recruiting
    • Parkinson Disease
    • Stalevo
    • Carbidopa and Levodopa Controlled Release Tablets
    • (no location specified)
    Jul 4, 2021

    Parkinson's Disease Trial in Italy, Luxembourg, Spain (continuous oral delivery of levodopa/carbidopa)

    Recruiting
    • Parkinson's Disease
    • continuous oral delivery of levodopa/carbidopa
    • Cassino, Italy
    • +3 more
    Jul 20, 2021